|1.||Kusrini, Eny: 1 article (01/2016)|
|2.||Amin, Nakisah Mat: 1 article (01/2016)|
|3.||Hashim, Fatimah: 1 article (01/2016)|
|4.||Estuningtyas, Ari: 1 article (01/2016)|
|5.||Azmi, Wan Nor Nadhirah Wan Noor: 1 article (01/2016)|
|6.||Kiyohara, Yasato: 1 article (06/2012)|
|7.||Miyake, Yoshikazu: 1 article (06/2012)|
|8.||Tanaka, Shunsuke: 1 article (06/2012)|
|9.||Araki, Sadao: 1 article (06/2012)|
|10.||Ly, Tony: 1 article (11/2008)|
|2.||Parkinson Disease (Parkinson's Disease)
11/01/2008 - "For example, alpha-synuclein is a protein associated in the pathology of Parkinson's disease, which is known to aggregate more rapidly in the presence of Al3+ and Cu2+. The 18C6 SNAPP distributions for alpha-synuclein change dramatically in the presence of 3 microM Al3+, revealing that Al3+ binding causes a significant change in the conformational dynamics of the monomeric form of this disordered protein. "
11/06/1990 - "The results indicate that anti-id 18C6 is a highly specific probe to assess the expression of the ganglioside antigenic epitope recognized by the L612 HuMAb on biopsied human tumor tissues."
11/06/1990 - "A murine anti-idiotype monoclonal antibody, alpha type, 18C6 (IgGl), was raised against an IgM HuMAb, L612, defining a tumor-associated ganglioside antigen (GM3) and used as a probe in a three step cell-binding assay (HuMAb + anti-id + biotinylated anti-mouse Ig). "
|4.||Melanoma (Melanoma, Malignant)
11/06/1990 - "The applicability of 18C6 in the three step cell-binding assay was tested first using a melanoma cell line, UCLASO-M12. "
11/06/1990 - "Anti-id 18C6 has an exclusive binding specificity for HuMAb L612, but does not interfere with the binding of L612 to antigen positive melanoma cell lines or to a purified antigen, GM3. "
|3.||Staphylococcal Protein A (A, Protein)
|4.||Silicon Dioxide (Sand)
|5.||Immunoglobulin M (IgM)
|7.||Aluminum Oxide (Sapphire)